Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Exploration of Targeted Anti-Tumor Therapy|November 7, 2022
The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectorsMaria Teresa Palano, Matteo Gallazzi, Martina Cucchiara, et al.
Cancer Letters|April 22, 2018
Acetyl-l-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathwaysDenisa Baci, Antonino Bruno, Barbara Bassani, et al.
International Journal of Molecular Sciences|August 26, 2022
Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer PathogenesisAntonino Bruno, Douglas M Noonan, Roberto Valli, et al.
Vaccines|October 26, 2021
Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer CellsAndrea De Lerma Barbaro, Maria Teresa Palano, Martina Cucchiara, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2006
Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor YGiovanna Tosi, Elisabetta Pilotti, Lorenzo Mortara, et al.
Frontiers in Oncology|July 30, 2014
Orchestration of angiogenesis by immune cellsAntonino Bruno, Arianna Pagani, Laura Pulze, et al.
International Journal of Cancer|October 31, 2009
Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalphaEnrica Balza, Barbara Carnemolla, Lorenzo Mortara, et al.
Frontiers in Endocrinology|August 9, 2020
Immunological Drivers in Graves' Disease: NK Cells as a Master SwitcherDaniela Gallo, Eliana Piantanida, Matteo Gallazzi, et al.
Frontiers in Cell and Developmental Biology|December 22, 2025
Evolving frontiers in bladder cancer immunotherapy: integrating BCG, immune checkpoints, viral vectors, nanotechnology, and CAR-based therapiesAnna Di Spirito, Gaia Zuccolotto, Anna Tosi, et al.
Cytometry|July 13, 2002
Grading of laboratories on CD4+ T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement errorAnnalisa Kunkl, Domenico Risso, Maria Paola Terranova, et al.
Pageof 9